Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03587740
Recruitment Status : Active, not recruiting
First Posted : July 16, 2018
Last Update Posted : January 11, 2022
Susan G. Komen Breast Cancer Foundation
Gateway for Cancer Research
Information provided by (Responsible Party):
Rachel Freedman, MD, MPH, Dana-Farber Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 30, 2026
Estimated Study Completion Date : August 30, 2029